PRISMA statement published – and endorsed by BioMed Central's journals
A new reporting guideline for systematic reviews and meta-analyses – the study design considered to produce the highest level of evidence for clinical decision-makers – has been published, and is endorsed in BioMed Central’s instructions to authors. The PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) statement is a revised an updated version of… Read more »